What is the catalog number for SMC3 Rabbit Polyclonal Antibody?

The catalog number for SMC3 Rabbit Polyclonal Antibody is orb316609.

What sizes are available for SMC3 Rabbit Polyclonal Antibody?

SMC3 Rabbit Polyclonal Antibody is available in the following size(s): 100 µg.

Is SMC3 Rabbit Polyclonal Antibody in stock?

SMC3 Rabbit Polyclonal Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

SMC3 Rabbit Polyclonal Antibody

Product Specifications

Product Name Alternative

Structural maintenance of chromosomes protein 3; SMC protein 3; SMC-3; Basement membrane-associated chondroitin proteoglycan; Bamacan; Chondroitin sulfate proteoglycan 6; Chromosome-associated polypeptide; hCAP; SMC3; BAM, BMH, CSPG6, SMC3L1

UniProt

Q9UQE7

Reactivity

Human, Mouse, Rat

Cross Reactivity

No cross-reactivity with other proteins.

Immunogen

A synthetic peptide corresponding to a sequence at the C-terminus of human SMC3, identical to the related mouse sequence.

Target

Structural maintenance of chromosomes protein 3

Clonality

Polyclonal

Conjugation

Unconjugated

Field of Research

Cancer Biology, Cell Biology, Epigenetics & Chromatin, Molecular Biology

Purification

Immunogen affinity purified.

Concentration

Adding 0.2 ml of distilled water will yield a concentration of 500 μg/ml.

Dilution

Immunohistochemistry (Paraffin-embedded Section), 0.5-1μg/ml, Human, Mouse, Rat Western blot, 0.1-0.5μg/ml, Human, Mouse, Rat

Form

Lyophilized

Molecular Weight

140 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

IHC, WB

Host or Source

Rabbit

Preservative

Each vial contains antibody formulated with stabilizing components, 0.9 mg NaCl, 0.2 mg Na2HPO4, and 0.05 mg NaN3. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.